AtriCure (ATRC) Director Regina Groves Sells 5,313 Shares

What Happened
Regina Groves, a director of AtriCure, sold 5,313 shares in an open-market transaction on September 11, 2026. The weighted average sale price was $54.22 per share, for total proceeds of approximately $288,071. This was a sale (not a purchase or option exercise), which is commonly a routine disposition and does not by itself indicate the director’s view of the company.

Key Details

• Transaction date: 2026-09-11 (reported on Form 4 filed 2026-09-14). Filing appears timely.
• Price: weighted average $54.22 per share; individual trade prices ranged from $54.09 to $54.38 (see footnote).
• Shares sold: 5,313; proceeds ≈ $288,071.
• Shares owned after transaction: not disclosed in the filing.
• Footnote: The sale was executed in multiple trades; the reported price is a weighted average and the reporting person will provide trade-level details upon request.
• No 10b5-1 plan, gift, exercise, or tax-withholding notation was indicated in the filing.

Context
Sales by company insiders can be for many reasons (diversification, personal liquidity, tax planning, etc.); a single open-market sale by a director is typically routine and should be considered alongside other insider activity and company fundamentals. If you track insider behavior, watch for patterns (multiple insiders selling or large, repeated purchases) rather than a lone routine sale.